Literature DB >> 16385445

Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria.

Laurent Gouya1, Caroline Martin-Schmitt, Anne-Marie Robreau, Frederic Austerlitz, Vasco Da Silva, Patrick Brun, Sylvie Simonin, Said Lyoumi, Bernard Grandchamp, Carole Beaumont, Herve Puy, Jean-Charles Deybach.   

Abstract

Erythropoietic protoporphyria (EPP) is an inherited disorder of heme biosynthesis that results from a partial deficiency of ferrochelatase (FECH). Recently, we have shown that the inheritance of the common hypomorphic IVS3-48C allele trans to a deleterious mutation reduces FECH activity to below a critical threshold and accounts for the photosensitivity seen in patients. Rare cases of autosomal recessive inheritance have been reported. We studied a cohort of 173 white French EPP families and a group of 360 unrelated healthy subjects from four ethnic groups. The prevalences of the recessive and dominant autosomal forms of EPP are 4% (95% confidence interval 1-8) and 95% (95% confidence interval 91-99), respectively. In 97.9% of dominant cases, an IVS3-48C allele is co-inherited with the deleterious mutation. The frequency of the IVS3-48C allele differs widely in the Japanese (43%), southeast Asian (31%), white French (11%), North African (2.7%), and black West African (<1%) populations. These differences can be related to the prevalence of EPP in these populations and could account for the absence of EPP in black subjects. The phylogenic origin of the IVS3-48C haplotypes strongly suggests that the IVS3-48C allele arose from a single recent mutational event. Estimation of the age of the IVS3-48C allele from haplotype data in white and Asian populations yields an estimated age three to four times younger in the Japanese than in the white population, and this difference may be attributable either to differing demographic histories or to positive selection for the IVS3-48C allele in the Asian population. Finally, by calculating the KA/KS ratio in humans and chimpanzees, we show that the FECH protein sequence is subject to strong negative pressure. Overall, EPP looks like a Mendelian disorder, in which the prevalence of overt disease depends mainly on the frequency of a single common single-nucleotide polymorphism resulting from a unique mutational event that occurred 60,000 years ago.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385445      PMCID: PMC1380220          DOI: 10.1086/498620

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  Bovine protoporphyria: the first nonhuman model of this hereditary photosensitizing disease.

Authors:  G R RUTH; S Schwartz; B Stephenson
Journal:  Science       Date:  1977-10-14       Impact factor: 47.728

Review 2.  The liver in protoporphyria.

Authors:  J R Bloomer
Journal:  Hepatology       Date:  1988 Mar-Apr       Impact factor: 17.425

3.  Ferrochelatase activity in human lymphocytes, as quantified by a new high-performance liquid-chromatographic method.

Authors:  E Rossi; K A Costin; P Garcia-Webb
Journal:  Clin Chem       Date:  1988-12       Impact factor: 8.327

4.  Recessive inheritance of erythropoietic protoporphyria with liver failure.

Authors:  R P Sarkany; G J Alexander; T M Cox
Journal:  Lancet       Date:  1994-10-01       Impact factor: 79.321

5.  Hepatobiliary implications and complications in protoporphyria, a 20-year study.

Authors:  M O Doss; M Frank
Journal:  Clin Biochem       Date:  1989-06       Impact factor: 3.281

6.  Genetic heterogeneity in erythropoietic protoporphyria: a study of the enzymatic defect in nine affected families.

Authors:  P G Norris; A V Nunn; J L Hawk; T M Cox
Journal:  J Invest Dermatol       Date:  1990-09       Impact factor: 8.551

7.  Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease.

Authors:  S Tutois; X Montagutelli; V Da Silva; H Jouault; P Rouyer-Fessard; K Leroy-Viard; J L Guénet; Y Nordmann; Y Beuzard; J C Deybach
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene.

Authors:  J Lamoril; S Boulechfar; H de Verneuil; B Grandchamp; Y Nordmann; J C Deybach
Journal:  Biochem Biophys Res Commun       Date:  1991-12-16       Impact factor: 3.575

9.  Genetic aspects of erythropoietic protoporphyria.

Authors:  L N Went; E C Klasen
Journal:  Ann Hum Genet       Date:  1984-05       Impact factor: 1.670

10.  An HPLC assay for rat liver ferrochelatase activity.

Authors:  F M Li; C K Lim; T J Peters
Journal:  Biomed Chromatogr       Date:  1987       Impact factor: 1.902

View more
  47 in total

1.  The diagnosis and management of erythropoietic protoporphyria.

Authors:  Manish Thapar; Herbert L Bonkovsky
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

2.  The low expression allele (IVS3-48C) of the ferrochelatase gene leads to low enzyme activity associated with erythropoietic protoporphyria.

Authors:  Tsuyoshi Tahara; Masayoshi Yamamoto; Reiko Akagi; Hideo Harigae; Shigeru Taketani
Journal:  Int J Hematol       Date:  2010-12-04       Impact factor: 2.490

Review 3.  [Erythropoietic protoporphyria : Clinical manifestations, diagnosis and new therapeutic possibilities].

Authors:  U Urbanski; J Frank; N J Neumann
Journal:  Hautarzt       Date:  2016-03       Impact factor: 0.751

4.  Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.

Authors:  Vincent Oustric; Hana Manceau; Sarah Ducamp; Rima Soaid; Zoubida Karim; Caroline Schmitt; Arienne Mirmiran; Katell Peoc'h; Bernard Grandchamp; Carole Beaumont; Said Lyoumi; François Moreau-Gaudry; Véronique Guyonnet-Dupérat; Hubert de Verneuil; Joëlle Marie; Herve Puy; Jean-Charles Deybach; Laurent Gouya
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

5.  Paralytic ileus and liver failure--an unusual presentation of advanced erythropoietic protoporphyria.

Authors:  Simone Negrini; Gabriele Zoppoli; Maurizio Setti; Maria Domenica Cappellini; Francesco Indiveri
Journal:  Dig Dis Sci       Date:  2008-11-14       Impact factor: 3.199

Review 6.  Identifying modifier genes of monogenic disease: strategies and difficulties.

Authors:  Emmanuelle Génin; Josué Feingold; Françoise Clerget-Darpoux
Journal:  Hum Genet       Date:  2008-09-11       Impact factor: 4.132

7.  C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload.

Authors:  Sharon D Whatley; Sarah Ducamp; Laurent Gouya; Bernard Grandchamp; Carole Beaumont; Michael N Badminton; George H Elder; S Alexander Holme; Alexander V Anstey; Michelle Parker; Anne V Corrigall; Peter N Meissner; Richard J Hift; Joanne T Marsden; Yun Ma; Giorgina Mieli-Vergani; Jean-Charles Deybach; Hervé Puy
Journal:  Am J Hum Genet       Date:  2008-09-04       Impact factor: 11.025

Review 8.  Genetic modifiers and oligogenic inheritance.

Authors:  Maria Kousi; Nicholas Katsanis
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

Review 9.  Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management.

Authors:  Manisha Balwani
Journal:  Mol Genet Metab       Date:  2019-01-24       Impact factor: 4.797

Review 10.  Erythropoietic protoporphyria.

Authors:  Mario Lecha; Hervé Puy; Jean-Charles Deybach
Journal:  Orphanet J Rare Dis       Date:  2009-09-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.